Your browser doesn't support javascript.
loading
Reply to Letter to the Editor by Dr. Terry J. Smith regarding teprotumumab and ototoxicity.
Bartalena, L; Marcocci, C; Tanda, M L; Marinò, M.
Affiliation
  • Bartalena L; Department of Medicine and Surgery, University of Insubria, Via Ravasi, 2, 21100, Varese, Italy. luigi.bartalena@uninsubria.it.
  • Marcocci C; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
  • Tanda ML; Department of Medicine and Surgery, University of Insubria, Via Ravasi, 2, 21100, Varese, Italy.
  • Marinò M; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
J Endocrinol Invest ; 45(8): 1603-1604, 2022 08.
Article in En | MEDLINE | ID: mdl-35633498
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Graves Ophthalmopathy / Ototoxicity Limits: Humans Language: En Journal: J Endocrinol Invest Year: 2022 Document type: Article Affiliation country: Italy
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Graves Ophthalmopathy / Ototoxicity Limits: Humans Language: En Journal: J Endocrinol Invest Year: 2022 Document type: Article Affiliation country: Italy